FUNDC1 expression positively correlated with SQSTM1 (Figure 10(d)) and MAP1LC3B (Figure 10(g)) in HCC patients (r = 0.107, p < 0.001; r = 0.34, p < 0.001). This evidence concerns the gene MAP1LC3B and hepatocellular carcinoma.